Please assess the completion status of the following clinical trial:

Trial Title: Double Blind Atorvastatin Amlodipine Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Holter monitoring at baseline which demonstrates a total of 15 minutes of ischemia and/or 3 ischemic events per 48 hours.~* Total cholesterol \> 5.2 mmol/L (200 mg/dL) on diet alone.~Exclusion Criteria:~* Myocardial infarction within 2 months prior to the study.~* Likelihood of requiring treatment during the study period with drugs not permitted by the study protocol.

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).